Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia

BACKGROUND: Statins reduce plasma low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hsCRP) levels. Rosuvastatin 10 mg daily appears to be more potent in reducing LDL-C than simvastatin 40 mg, but the relative effect of these two statin doses on hsCRP is unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Cheng, Hu, Miao, Wu, Yong-Jian, Tomlinson, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568069/
https://www.ncbi.nlm.nih.gov/pubmed/26365713
http://dx.doi.org/10.1186/s12944-015-0116-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568069/
https://www.ncbi.nlm.nih.gov/pubmed/26365713
http://dx.doi.org/10.1186/s12944-015-0116-0

Ejemplares similares